Capital Mãe

计划入组 446 人

CAPITAL OFFLOAD-SHOCK

计划入组 456 人 · 首次发布于 2026 年 8 月 11 日

Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders

计划入组 14 人 · 首次发布于 2009 年 2 月 18 日

PAD4 inhibitors(Capital Medical University)

IGC-AD1

Ad-TD-nsIL12(Capital Medical University)

Noble Pharmaceuticals, LLC

United States

NOBLE GAS SOLUTIONS, INC.

United States

Noble Panacea Labs, Inc.

United States

Greenwich LifeSciences Advances Phase III FLAMINGO-01 Trial for HER2-Positive Breast Cancer Immunotherapy

PolTREG Establishes U.S. Subsidiary Immuthera and Receives Positive EMA Opinion for Type 1 Diabetes Cell Therapy

Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment